Immix Biopharma Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -42.8% | +3,271.4% | -18.1% | +33.7% | +15.2% | +356.9% | |
| – | -43.0% | +3,317.0% | -18.1% | +32.8% | +2.1% | +401.2% | |
| – | -46.7% | +4,411.7% | -23.8% | +30.3% | +1.0% | +431.2% | |
| – | -46.7% | +4,411.7% | -23.8% | +30.3% | +1.0% | +467.9% | |
| – | -27.5% | -79.8% | +894.1% | +358.4% | +68.4% | – | |
| – | -24.0% | -22.6% | -37.5% | – | – | – | |
| – | +14.8% | -96.2% | +765.3% | +112.9% | +160.5% | +13.9% | |
| – | +14.8% | -96.2% | +530.2% | +192.3% | +133.4% | +16.4% | |
| – | +0.0% | -98.8% | – | – | – | +113.6% | |
| – | +1.9% | -43.4% | +0.1% | +901.6% | +276.0% | +1.0% | |
| – | – | – | -26.8% | +24.7% | -19.2% | +607.8% | |
| – | – | – | – | – | – | – | |
| – | +130.3% | -52.8% | +278.1% | +24.9% | +63.1% | +16.5% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.